I have been active in a European research project the VIP= Very old Intensive care Patients and since the start of the pandemic we have had a prospective study running in elderly COVID-19 patients in the ICU. We constantly have been surprised by the lack of good evidence for core issues in intensive care for the elderly, and suggested a research agenda back in 2017 (https://doi.org/10.1007/s00134-017-4718-z). Our task has first and foremost been concentrated on various outcomes and explanatory variables. We have recently also started to find peculiar trends in the treatment of the elderly Covid-19 patients. Our data suggested that they had en excess mortality during the second surge, and also that it seems that systemic steroids given to this group may result in increased mortality, on contrast to the less old COVID-19 patients. It would be good to start a discussion about this, and feel free to comment and suggest other issues related to this topic.
You can also have a look at our web-page if you are interested in contribute (https://vipstudy.org/)
Hans Flaatten